About Fenton Le Bon
Form D filings for Molecular World Health in 2023 list Fenton Le Bon as executive officer and director.
Fenton Le Bon first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Fenton Le Bon in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Fenton Le Bon works with at each company, as listed on that company's latest Form D.
Molecular World Health, Inc. · Form D, Feb 16, 2023
DP
Donald Pakosh
Chief Financial Officer and director
JP
Josh Pendrick
Director
PM
Paula Mestayer
Executive officer and director
RI
Richard Mestayer III
Executive officer and director